Long-term use of procaine amide following acute myocardial infarction.
D000974:Antibodies, Antinuclear; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D001168:Arthritis / Q000139:chemically induced; D001219:Aspartate Aminotransferases / Q000097:blood; D001806:Blood Urea Nitrogen; D003645:Death, Sudden; D003875:Drug Eruptions; D004562:Electrocardiography; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D009504:Neutrophils; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors; D014693:Ventricular Fibrillation / Q000517:prevention & control
D000974:Antibodies, Antinuclear; D001219:Aspartate Aminotransferases; D011342:Procainamide